TDOC (Teladoc Health, Inc.)

Insider Trading Activity

Every open-market purchase and sale reported by TDOC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
1
code P
Sales
3
code S
Reporting Insiders
25
current holders
TDOC — Recent Form 4 Transactions (latest 2026-09-03)
FiledInsiderRole TypeSharesValue
2026-09-03 Joseph Ronald Catapano Chief Accounting Officer MIXED
2026-09-03 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2026-09-03 Carlos Nueno President, International MIXED
2026-09-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY MIXED
2026-09-03 Kelly Bliss President, U.S. Group Health MIXED
2026-09-03 Fernando M. Rodrigues President of BetterHelp MIXED
2026-09-01 Michael F Grasher Chief Financial Officer A
2026-08-04 Mark V Anquillare Director A
2026-07-06 Kelly Bliss President, U.S. Group Health Sell
2026-07-06 Joseph Ronald Catapano Chief Accounting Officer MIXED
2026-07-01 Kelly Bliss President, U.S. Group Health Sell
2026-06-12 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2026-06-04 Fernando M. Rodrigues President of BetterHelp Sell
2026-06-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY MIXED
2026-06-03 Joseph Ronald Catapano Chief Accounting Officer MIXED
2026-06-03 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2026-06-03 Fernando M. Rodrigues President of BetterHelp MIXED
2026-06-03 Kelly Bliss President, U.S. Group Health MIXED
2026-06-03 Carlos Nueno President, International MIXED
2026-05-21 Kenneth H Paulus Director A
2026-05-21 Mark Douglas Smith Director A
2026-05-21 DAVID L SHEDLARZ Director M
2026-05-21 Catherine Jacobson Director M
2026-05-21 DAVID B SNOW JR Director M
2026-05-21 Sandra L Fenwick Director A
2026-04-03 Joseph Ronald Catapano Chief Accounting Officer MIXED
2026-04-01 SUSAN R SALKA Director A
2026-03-12 Kelly Bliss President, U.S. Group Health MIXED
2026-03-12 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2026-03-03 Carlos Nueno President, International MIXED
2026-03-03 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2026-03-03 Kelly Bliss President, U.S. Group Health MIXED
2026-03-03 Joseph Ronald Catapano Chief Accounting Officer MIXED
2026-03-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY MIXED
2026-03-03 Fernando M. Rodrigues President of BetterHelp MIXED
2026-02-19 Michael S Smith Director A
2026-01-06 Joseph Ronald Catapano Chief Accounting Officer MIXED
2025-12-22 Jason Eric Evans Director M
2025-12-11 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2025-12-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY MIXED
2025-12-03 Kelly Bliss President, U.S. Group Health MIXED
2025-12-03 Carlos Nueno President, International MIXED
2025-12-03 Fernando M. Rodrigues President of BetterHelp MIXED
2025-11-17 Kenneth H Paulus Director Buy
2025-10-03 Joseph Ronald Catapano Chief Accounting Officer MIXED
2025-09-22 Jason Eric Evans Director M
2025-09-11 CHARLES DIVITA III CHIEF EXECUTIVE OFFICER MIXED
2025-09-03 Kelly Bliss President, U.S. Group Health MIXED
2025-09-03 Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY MIXED
2025-09-03 Carlos Nueno President, International MIXED
TDOC — Current Insider Holders
InsiderRole Shares HeldValue
10%+ Owner 4,430,396
10%+ Owner 3,780,468
10%+ Owner 2,641,986
10%+ Owner 2,500,468
10%+ Owner 2,480,468
CHIEF EXECUTIVE OFFICER 687,176
10%+ Owner 558,756
Director 502,231
CHIEF EXECUTIVE OFFICER 458,865
10%+ Owner 273,212
Head of Research & Development 224,007
Director 165,032
CHIEF FINANCIAL OFFICER 142,835
Director 130,785
CHIEF LEGAL OFFICER, SECRETARY 115,611
Advisor to the CEO 99,929
President, U.S. Group Health 89,737
CHIEF OPERATING OFFICER 82,527
Chief Technology Officer 75,410
Director 66,853
President, International 62,227
Chief Sales Officer 61,459
Director 61,266
Director 57,098
Director 49,986
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the TDOC quote page; the site-wide leaderboard is on the insider transactions hub.